Active Rheumatoid Arthritis: Clinical Trials

6 trials for Active Rheumatoid Arthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 1, Unknown 1

Follow Active Rheumatoid Arthritis: new trials by email Literature Review of Active Rheumatoid Arthritis trials Research Report on Active Rheumatoid Arthritis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Solumedrol - Active Rheumatoid Arthritis
Phase 3UnknownSohag University2682024-05-012024-06-13
Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
Adalimumab, Methotrexate, Folic Acid - Active Rheumatoid Arthritis
Phase 3CompletedCinnagen1362015-11-182021-02-02
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
Treatment I, Treatment II, Treatment III - Active Rheumatoid Arthritis
Phase 3TerminatedSun Pharmaceutical Industries Limited1502015-11-012021-11-19
Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870
CDP870 - Active Rheumatoid Arthritis
Phase 3CompletedAstellas Pharma Inc862011-01-012015-11-16
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Abatacept, Placebo - Active Rheumatoid Arthritis
Phase 3CompletedBristol-Myers Squibb502007-05-012012-01-18
Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
Etanercept - Active Rheumatoid Arthritis
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer6152000-10-012023-12-13

Narrower conditions

Arthritis (1)  ·  Arthritis, Rheumatoid (1)

Broader conditions

Joint Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Rheumatic Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Abatacept (1)  ·  Adalimumab (1)  ·  Certolizumab Pegol (1)  ·  Etanercept (1)  ·  Folic Acid (1)  ·  Methotrexate (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Prednisolone (1)

Sponsors

Astellas Pharma Inc (1)  ·  Bristol-Myers Squibb (1)  ·  Cinnagen (1)  ·  Sohag University (1)  ·  Sun Pharmaceutical Industries Limited (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

Belgium (3)  ·  Netherlands (3)  ·  Germany (2)  ·  Spain (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Iran (1)

Top investigators

Ahmadreza Jamshidi, Professor (1)

Results publications

PMID 18050208, PMID 22915624, PMID 27175292, PMID 28728599